Percutaneous core needle biopsy versus open biopsy in diagnostics of bone and soft tissue sarcoma: a retrospective study

European Journal of Medical Research

Ruediger von Eisenhart-Rothe¹  Hans Rechl¹  Rainer Burgkart¹  Johannes Schauwecker¹  Ulrich Lenze¹  Chlodwig Kirchhoff²  Florian Pohlig¹ 

[1] Department of Orthopaedic Surgery, Klinikum rechts der Isar, Technische Universitaet Muenchen, Ismaningerstrasse 22, 81675, Munich, Germany;Department of Trauma Surgery, Klinikum rechts der Isar, Technische Universitaet Muenchen, Ismaningerstrasse 22, 81675, Munich, Germany

关键词: Histopathology;    Malignancy;    FNA;    Sarcoma;    CNB;    Core needle biopsy;    Open biopsy;    Biopsy;   

Others  :  820211
DOI  :  10.1186/2047-783X-17-29

 received in 2012-04-09, accepted in 2012-10-09,  发布年份 2012

【 摘 要 】

Background

Biopsy is a crucial step within the diagnostic cascade in patients with suspected bone or soft tissue sarcoma. Open biopsy is still considered the gold standard. However, recent literature suggests similar results for percutaneous biopsy techniques. Therefore, the aim of this retrospective analysis was to compare open and percutaneous core needle biopsy (CNB) regarding their accuracy in diagnosis of malignant musculoskeletal lesions.

Methods

From January 2007 to December 2009, all patients with suspected malignant primary bone or soft tissue tumour undergoing a percutaneous CNB or open biopsy and a subsequent tumour resection at our department were identified and enrolled. Sensitivities, specificities, positive predictive values (PPV), negative predictive values (NPV) and diagnostic accuracy were calculated for both biopsy techniques and compared using Fisher’s exact test.

Results

A total of 77 patients were identified and enrolled in this study. Sensitivity, specificity, PPV, NPV and diagnostic accuracy were 100% for CNB in bone tumours. Sensitivity (95.5%), NPV (91.7%) and diagnostic accuracy (93.3%) for open biopsy in bone tumours showed slightly inferior results without statistical significance (p > 0.05). In soft tissue tumours favourable results were obtained in open biopsies compared to CNB with differences regarding sensitivity (100% vs. 81.8%, p = 0.5), NPV (100% vs. 50%, p = 0.09) and diagnostic accuracy (100% vs. 84.6%, p = 0,19) without statistical significance. The overall diagnostic accuracy was 92.9% for CNB and 98.0% for open biopsy (p = 0.55). A specific diagnosis could be obtained in 84.2% and 93.9%, respectively (p = 0.34).

Conclusion

In our study we found moderately inferior results for the percutaneous biopsy technique compared to open biopsy in soft tissue tumours whereas almost equal results were obtained for both biopsy techniques for bone tumours. Thus, CNB is a safe, minimal invasive and cost-effective technique for diagnosing bony lesions. In soft tissue masses, the indication for percutaneous core needle biopsy needs to be made carefully by an experienced orthopaedic oncologist with respect to the suspected entity, size of necrosis and location of the lesion to avoid incorrect or deficient results.

【 授权许可】

   
2012 Pohlig et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Delling G: Diagnosis of bone tumors. Verh Dtsch Ges Pathol 1998, 82:121-132.
• [2]Steinau HU, Homann HH, Drucke D, Torres A, Soimaru D, Vogt P: [Resection method and functional restoration in soft tissue sarcomas of the extremities]. Chirurg 2001, 72:501-513.
• [3]Jaffe HL: Problems of Classification and Diagnosis (Introduction). In Tumors and Tumorous Conditions of the Bones and Joints. Philadelphia: Lea & Febiger; 1958.
• [4]Bickels J, Jelinek JS, Shmookler BM, Neff RS, Malawer MM: Biopsy of musculoskeletal tumors. Current concepts. Clin Orthop Relat Res 1999, 368:212-219.
• [5]Pohlig F, Kirchhoff C, Gradinger R, von Eisenhart-Rothe R, Rechl H: Bone and soft tissue sarcoma: principles of biopsy. InFo Onkologie 2010, 13:34-37.
• [6]Shives TC: Biopsy of soft-tissue tumors. Clin Orthop Relat Res 1993, 289:32-35.
• [7]Mankin HJ, Mankin CJ, Simon MA: The hazards of the biopsy, revisited. Members of the musculoskeletal tumor society. J Bone Joint Surg Am 1996, 78:656-663.
• [8]Issakov J, Flusser G, Kollender Y, Merimsky O, Lifschitz-Mercer B, Meller I: Computed tomography-guided core needle biopsy for bone and soft tissue tumors. Isr Med Assoc J 2003, 5:28-30.
• [9]Mitsuyoshi G, Naito N, Kawai A, Kunisada T, Yoshida A, Yanai H, Dendo S, Yoshino T, Kanazawa S, Ozaki T: Accurate diagnosis of musculoskeletal lesions by core needle biopsy. J Surg Oncol 2006, 94:21-27.
• [10]Altuntas AO, Slavin J, Smith PJ, Schlict SM, Powell GJ, Ngan S, Toner G, Choong PF: Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours. ANZ J Surg 2005, 75:187-191.
• [11]Torriani M, Etchebehere M, Amstalden E: Sonographically guided core needle biopsy of bone and soft tissue tumors. J Ultrasound Med 2002, 21:275-281.
• [12]Welker JA, Henshaw RM, Jelinek J, Shmookler BM, Malawer MM: The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer 2000, 89:2677-2686.
• [13]Chen J, Niu Z, Yao L, Xiao M, Fan J: cDNA cloning and sequencing of MH2 domain of Smad2 from human dental pulp cells. Chin J Dent Res 1999, 2:14-18.
• [14]Fraser-Hill MA, Renfrew DL: Percutaneous needle biopsy of musculoskeletal lesions. 1. Effective accuracy and diagnostic utility. AJR Am J Roentgenol 1992, 158:809-812.
• [15]McCarthy EF: CT-guided needle biopsies of bone and soft tissue tumors: a pathologist's perspective. Skeletal Radiol 2007, 36:181-182.
• [16]Sung KS, Seo SW, Shon MS: The diagnostic value of needle biopsy for musculoskeletal lesions. Int Orthop 2009, 33:1701-1706.
• [17]Strauss DC, Qureshi YA, Hayes AJ, Thway K, Fisher C, Thomas JM: The role of core needle biopsy in the diagnosis of suspected soft tissue tumours. J Surg Oncol 2010, 102:523-529.
• [18]Kasraeian S, Allison DC, Ahlmann ER, Fedenko AN, Menendez LR: A comparison of fine-needle aspiration, core biopsy, and surgical biopsy in the diagnosis of extremity soft tissue masses. Clin Orthop Relat Res 2010, 468:2992-3002.
• [19]Simon MA: Biopsy of musculoskeletal tumors. J Bone Joint Surg Am 1982, 64:1253-1257.
• [20]Cormier JN, Pollock RE: Soft tissue sarcomas. CA Cancer J Clin 2004, 54:94-109.
• [21]Antonescu CR: The role of genetic testing in soft tissue sarcoma. Histopathology 2006, 48:13-21.
• [22]Davicioni E, Wai DH, Anderson MJ: Diagnostic and prognostic sarcoma signatures. Mol Diagn Ther 2008, 12:359-374.
• [23]Contreras O, Burdiles A: Diagnosis of bone lesions using image guided percutaneous biopsy. Rev Med Chil 2006, 134:1283-1287. [Article in Spanish]
• [24]Jelinek JS, Murphey MD, Welker JA, Henshaw RM, Kransdorf MJ, Shmookler BM, Malawer MM: Diagnosis of primary bone tumors with image-guided percutaneous biopsy: experience with 110 tumors. Radiology 2002, 223:731-737.
• [25]Absher KJ, Witte DA, Truong LD, Ramzy I, Mody DR, Ostrowski ML: Biopsy of osseous metastasis of retroperitoneal paraganglioma. Report of a case with cytologic features and differential diagnostic considerations. Acta Cytol 2001, 45:249-253.
• [26]Bennert KW, Abdul-Karim FW: Fine needle aspiration cytology vs. needle core biopsy of soft tissue tumors. A comparison. Acta Cytol 1994, 38:381-384.